ORGO
Organogenesis Holdings Inc.
Nasdaq Pharmaceutical Preparations Accelerated filer

Key Financials

Net Income
$37.0M
↑ 4201.0%
Revenue
$564.2M
↑ 17.0%
EPS (Diluted)
$0.15
↑ 1600.0%
Total Liabilities
$164.8M
↑ 46.4%
Total Assets
$598.7M
↑ 20.3%
Shareholders' Equity
$300.1M
↑ 14.2%
Cash & Equivalents
$93.7M
↓ 30.9%
Operating Income
$44.7M
↑ 3583.6%

Recent SEC Filings

Form Type Filed Date Link
8-K 6/16/2026 View on SEC
10-Q 5/7/2026 View on SEC
8-K 5/7/2026 View on SEC
ARS 4/30/2026 View on SEC
DEF 14A 4/30/2026 View on SEC
4 4/24/2026 View on SEC
4 3/11/2026 View on SEC
4 3/11/2026 View on SEC
4 3/3/2026 View on SEC
4/A 3/3/2026 View on SEC

Company Information

Field Value
Ticker ORGO
Company Name Organogenesis Holdings Inc.
CIK 1661181
Sector Pharmaceutical Preparations
Industry Accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 781-575-0775